Sharps Technology, Inc. (STSS)

USD 4.75

(-9.35%)

Revenue Summary of Sharps Technology, Inc.

  • Sharps Technology, Inc.'s latest annual revenue in 2023 was - USD , down 0.0% from previous year.
  • Sharps Technology, Inc.'s latest quarterly revenue in 2024 Q2 was - USD , down -100.0% from previous quarter.
  • Sharps Technology, Inc. reported a annual revenue of - USD in annual revenue 2022, down 0.0% from previous year.
  • Sharps Technology, Inc. reported a annual revenue of - USD in annual revenue 2021, down 0.0% from previous year.
  • Sharps Technology, Inc. reported a quarterly revenue of - USD for 2024 Q2, down -100.0% from previous quarter.
  • Sharps Technology, Inc. reported a quarterly revenue of -8226.00 USD for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of Sharps Technology, Inc. (2023 - 2019)

Historical Annual Revenue of Sharps Technology, Inc. (2023 - 2019)

Year Revenue Revenue Growth
2023 - USD 0.0%
2022 - USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%

Peer Revenue Comparison of Sharps Technology, Inc.

Name Revenue Revenue Difference
Akoya Biosciences, Inc. 96.63 Million USD 100.0%
AngioDynamics, Inc. 303.91 Million USD 100.0%
AtriCure, Inc. 399.24 Million USD 100.0%
Avinger, Inc. 7.65 Million USD 100.0%
Azenta, Inc. 665.07 Million USD 100.0%
BioLife Solutions, Inc. 143.27 Million USD 100.0%
The Cooper Companies, Inc. 3.59 Billion USD 100.0%
Daxor Corporation 1.28 Million USD 100.0%
Ekso Bionics Holdings, Inc. 18.27 Million USD 100.0%
Femasys Inc. 1.07 Million USD 100.0%
GlucoTrack, Inc. - USD NaN%
Harvard Bioscience, Inc. 112.25 Million USD 100.0%
Hologic, Inc. 4.03 Billion USD 100.0%
ICU Medical, Inc. 2.25 Billion USD 100.0%
Intuitive Surgical, Inc. 7.12 Billion USD 100.0%
KORU Medical Systems, Inc. 28.51 Million USD 100.0%
LeMaitre Vascular, Inc. 193.48 Million USD 100.0%
Innovative Eyewear, Inc. 1.15 Million USD 100.0%
Innovative Eyewear, Inc. 1.15 Million USD 100.0%
Masimo Corporation 2.04 Billion USD 100.0%
Microbot Medical Inc. - USD NaN%
Meihua International Medical Technologies Co., Ltd. 97.09 Million USD 100.0%
Merit Medical Systems, Inc. 1.25 Billion USD 100.0%
Nephros, Inc. 14.23 Million USD 100.0%
NovoCure Limited 509.33 Million USD 100.0%
NEXGEL, Inc. 4.08 Million USD 100.0%
NEXGEL, Inc. 4.08 Million USD 100.0%
Singular Genomics Systems, Inc. 2.91 Million USD 100.0%
OraSure Technologies, Inc. 405.47 Million USD 100.0%
Pro-Dex, Inc. 53.84 Million USD 100.0%
Pulse Biosciences, Inc. - USD NaN%
Predictive Oncology Inc. 1.78 Million USD 100.0%
Precision Optics Corporation, Inc. 19.1 Million USD 100.0%
QuidelOrtho Corporation 2.99 Billion USD 100.0%
Repligen Corporation 638.76 Million USD 100.0%
Sanara MedTech Inc. 64.98 Million USD 100.0%
STAAR Surgical Company 322.41 Million USD 100.0%
Utah Medical Products, Inc. 50.22 Million USD 100.0%
DENTSPLY SIRONA Inc. 3.96 Billion USD 100.0%
Jin Medical International Ltd. 19.82 Million USD 100.0%